Dr. Manjiri Bakre is a Cell Biology and Cell Signaling veteran with 18 years’ experience in research and technology in India, US and Singapore. She founded OncoStem with the vision of developing and delivering innovative, cost effective and reliable tests for personalized cancer treatment planning.
Previously she has worked in academia at Mount Sinai School of Medicine, NYC and Moores Cancer Center, UCSD and in the industry as well. Her last job at Philips Research involved the development of Point of Care diagnostics.
OncoStem Diagnostics is developing novel diagnostic tests which will predict a patient’s ‘risk of recurrence’ of cancer and prescribe targeted drugs and therapies to minimize this risk. OncoStem’s first focus is breast cancer.
Ajit Singh focuses on early-stage Technology and Life Science investments. He currently represents Artiman on the boards of Aditazz, CardioDx, Click Diagnostics, CORE Diagnostics, MedECube and OncoStem. A Consulting Professor in the School of Medicine at Stanford University, Ajit has two published books and five patents under his belt.
Stage I-III Breast Cancer Recurrence Risk Assessment